Treatment of liver diseases with camp responsive element binding protein 3 like 3 (creb3l3) inhibitors
Номер патента: EP4395888A1
Опубликовано: 10-07-2024
Автор(ы): Aris BARAS, Luca Andrea LOTTA, Niek VERWEIJ
Принадлежит: Regeneron Pharmaceuticals Inc
Опубликовано: 10-07-2024
Автор(ы): Aris BARAS, Luca Andrea LOTTA, Niek VERWEIJ
Принадлежит: Regeneron Pharmaceuticals Inc
Реферат: The present disclosure provides methods of treating subjects having a liver disease with a CAMP Responsive Element Binding Protein 3 Like 3 (CREB3L3) inhibitor, and methods of identifying subjects having an increased risk of developing a liver disease.
Kit for predicting or diagnosing nonalcoholic fatty liver disease, and method for diagnosing nonalcoholic fatty liver disease
Номер патента: AU2020323825B2. Автор: Won Kim,Giljae Lee,Gwang Pyo Ko,Hyun Ju You. Владелец: Kobiolabs Inc. Дата публикации: 2024-05-09.